While looking for a cholesterol-lowering statin to check a heart attack, deciding what is good, what is not requires calculation of more than a normal cholesterol level. A government task force said that the common medications are going to be most useful to some people from age group 40 years to 75 years, whose cardiovascular disease risk is at least 10% over the coming decade.
However, the US Preventive Services Task Force drafted some guidelines on Monday, leaving some wiggle room. They suggested that certain patients who aren’t at quite as high a risk still could benefit and must weigh the pros and cons for themselves.
Dr. Douglas Owens, a Stanford University professor and task force member, explained that the advantages of statins will be the largest in the people who are most vulnerable.
The recommendations are quite alike controversial guidelines that the American Heart Association and American College of Cardiology gave in 2013.
For over 20 years, Crestor, Zocor, Lipitor and other statins have been the set treatment for cutting cholesterol. They work by limiting its production in the liver. Generally, Statins lower cholesterol levels by nearly 25% to 35%. They are recommended for the ones already suffering from heart disease. The real question is who should use them to avoid heart disease initially.